Close Menu

John Hussman is not a scientist — he's a fund manager. The former economics professor runs the $6 billion Hussman Strategic Growth Fund, where he has a reputation for thoroughly researching potential investments and analyzing the markets, says Fortune's Scott Cendrowski. Now, Hussman is applying his research skills to understanding autism. Ever since his son was diagnosed with the disorder as a child, Hussman has focused his attention on finding its genetic causes.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.